Assertio Therapeutics

Assertio Therapeutics(ASRT)

Assertio Therapeutics, Inc. (formerly Depomed, Inc.) is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.

Trade Name	Drug Name	Approved	Patent Expires	Indication
Cambia	Diclofenac	2009-06-17	2026-2035	Juvenile arthritis , Ankylosing spondylitis , Rheumatoid arthritis , Photophobia , Inflammation , Osteoarthritis , Dysmenorrhea , Keratosis
Proquin	Ciprofloxacin	2005-05-19	2025-2038	Neutropenia , Prostatitis , Fever , Urinary tract infections , Sinusitis , Typhoid fever , Diarrhea , Bacterial infections , Gonorrhea , Intraabdominal infections , Pseudomonas infections , Bacterial skin diseases , Osteomyelitis , Escherichia coli infections , Campylobacter infections , Bacterial conjunctivitis , Staphylococcal infections , Infectious arthritis , Pyelonephritis , Proteus infections , Anthrax , Klebsiella infections , Otitis externa , Haemophilus infections , Protozoan infections , Cystitis , Dysentery , Bacteroides infections , Leukemia , Septic shock , Ulcerative colitis , Ankylosing spondylitis , Vomiting , Nausea , Sarcoidosis , Thrombocytopenic purpura idiopathic , Pulmonary tuberculosis , Mycosis fungoides , Systemic lupus erythematosus , Rheumatic diseases , Bursitis , Keratitis , Allergic rhinitis perennial , Thyroiditis , Iritis , Hypercalcemia , Brain edema , Pemphigus , Addison disease , Collagen diseases , Dermatitis herpetiformis , Psoriasis , Atopic dermatitis , Pruritus , Inflammation , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Shock , Pruritus ani , Adrenal insufficiency , Status asthmaticus , Contact dermatitis , Hemorrhoids , Congenital adrenal hyperplasia
Zipsor	Diclofenac	2009-06-16	2026-2035	Juvenile arthritis , Ankylosing spondylitis , Rheumatoid arthritis , Photophobia , Inflammation , Osteoarthritis , Dysmenorrhea , Keratosis
Sympazan	Clobazam	2018-11-01	2024-2040	Lennox gastaut syndrome, Seizures
Otrexup	Methotrexate	2013-10-11	2026-2033	Leukemia, Juvenile arthritis, Psoriatic arthritis, Breast neoplasms, Psoriasis, Stomach neoplasms, Esophageal neoplasms, Rheumatoid arthritis, Lung neoplasms, Crohn disease, Precursor cell lymphoblastic leukemia-lymphoma, Hydatidiform mole, Osteosarcoma, Arthritis, Mycosis fungoides, Testicular neoplasms, Choriocarcinoma